Oxford Biomedica (LON: OXB) has lowered its full-year 2026 revenue and profitability guidance after changes in customer ordering patterns and delays at its US facility, despite reporting record new client activity
Traders Cafe with Zak Mir: Bulletin Board Heroes, Friday 7th August 2026
Zak Mir takes a charting look at some of the most closely followed small caps on the London Stock Exchange. Today’s charts are the FTSE 100, DAX, Dow, Bitcoin, Ethereum, Gold,
RNS Hotlist with Zak Mir: GDWN, AXL, TLM, OXB, GELN & AMRQ
The Telegraph: The Cambridge diversity scramble that led to Arday fiasco: University accused of ‘going through the motions’ when it appointed its youngest black professor
Traders Cafe with Zak Mir: Bulletin Board Heroes, Weekend Edition, Sunday 17th August 2025
Zak Mir takes a charting look at some of the most closely followed small caps on the London Stock Exchange. Today’s charts are FTSE 100, DAX, Dow, Bitcoin, Gold, Audioboom,
Traders Cafe with Zak Mir: Bulletin Board Heroes, Friday 3rd May 2024
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s charts are FTSE 100, Dax, Dow, Bitcoin, Gold, Angus, Altitude, Anglo
Share Talk Weekly Small Cap Movers & Shakers, Saturday 23rd April 2022
With the uncertainty overshadowing Oilex (ASX:AIM: OEX) after the Cambay India C-77H Re-frac Update & Revised Gas Sales Contract announcement on the 14th of April 2022.
Oxford Biomedica PLC (AIM:OXB) enter into an $842.5 Million Exclusive Worldwide Licence Agreement
OXB and Axovant Sciences Licence Agreement